FEP Performance — First Trust Europe AlphaDEX Fund
Data updated: 2026-08-21
FEP returned +7.28% year to date and +22.77% over one year to Jun 2026. Annualised returns are +22.48% over 3 years and +9.90% over 5 years. The fund beat its Europe Equity category average: $100 invested three years ago grew to $184, against $151 for the category, and to $123 over one year, against $114. Volatility over the past three years was 15.05% a year. In the 12 months to Jun 2026 the fund took in a net $153.4M, and assets reached $505.30M.
FEP Growth of $100
What $100 invested in First Trust Europe AlphaDEX Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Europe Equity category average over the same months.
| Period | FEP | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $123 | $114 |
| 3 years (Jul 2023 – Jun 2026) | $184 | $151 |
| 5 years (Jul 2021 – Jun 2026) | $160 | $141 |
| Since data start (Jul 2019 – Jun 2026) | $204 | $183 |
FEP Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +7.28% |
| 1 year | +22.77% |
| 3 years (annualised) | +22.48% |
| 5 years (annualised) | +9.90% |
FEP Annual Returns
Calendar-year total returns of First Trust Europe AlphaDEX Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +7.28% |
| 2025 | +55.13% |
| 2024 | +3.70% |
| 2023 | +16.02% |
| 2022 | −22.89% |
| 2021 | +16.55% |
| 2020 | +4.98% |
| 2019 (Jul–Dec) | +7.87% |
FEP Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +6.0% | +3.6% | −7.6% | +6.6% | +2.3% | −3.1% | — | — | — | — | — | — |
| 2025 | +4.9% | +5.6% | +2.4% | +5.2% | +8.4% | +4.7% | −0.2% | +4.2% | +3.3% | −0.2% | +1.2% | +5.5% |
| 2024 | −2.2% | +1.6% | +5.0% | −1.7% | +7.5% | −5.0% | +3.8% | +1.8% | +1.0% | −4.0% | −1.3% | −2.2% |
| 2023 | +10.3% | −1.4% | −1.1% | +1.8% | −6.3% | +6.2% | +4.8% | −4.0% | −3.9% | −4.9% | +10.5% | +4.8% |
| 2022 | −5.1% | −5.8% | −0.2% | −7.5% | +2.9% | −13.1% | +3.8% | −6.8% | −11.6% | +9.2% | +12.6% | −0.7% |
| 2021 | −1.2% | +2.0% | +4.8% | +4.5% | +5.2% | −3.4% | +2.8% | +1.8% | −5.3% | +3.9% | −3.8% | +5.0% |
| 2020 | −2.8% | −8.6% | −22.4% | +8.6% | +6.9% | +2.4% | +5.4% | +7.4% | −2.9% | −5.2% | +16.0% | +6.3% |
| 2019 | — | — | — | — | — | — | −2.6% | −2.5% | +3.2% | +3.6% | +2.0% | +4.2% |
FEP Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 15.05%
- 3-year Sharpe ratio: 1.19 (vs 4.5% risk-free rate)
- Best month: +10.50% (Nov 2023)
- Worst month: −7.58% (Mar 2026)
FEP Fund Flows
Monthly money in and out of First Trust Europe AlphaDEX Fund, from SEC Form N-PORT.
- 12-month net flow: $153.4M
- 12-month gross sales (incl. reinvestments): $162.1M
- Sales ÷ redemptions: 18.55×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $5.7M | $0 | $5.7M |
| May 2026 | $0 | $2.9M | −$2.9M |
| Apr 2026 | $0 | $5.8M | −$5.8M |
| Mar 2026 | $16.5M | $0 | $16.5M |
| Feb 2026 | $49.2M | $0 | $49.2M |
| Jan 2026 | $11.0M | $0 | $11.0M |
| Dec 2025 | $39.7M | $0 | $39.7M |
| Nov 2025 | $0 | $0 | $0 |
| Oct 2025 | $5.1M | $0 | $5.1M |
| Sep 2025 | $0 | $0 | $0 |
| Aug 2025 | $27.6M | $0 | $27.6M |
| Jul 2025 | $7.2M | $0 | $7.2M |
FEP Assets Under Management
Net assets of First Trust Europe AlphaDEX Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $505.30M |
| 2026-03-31 | $487.67M |
| 2025-12-31 | $408.45M |
| 2025-09-30 | $343.93M |
| 2025-06-30 | $287.96M |
| 2025-03-31 | $223.61M |
| 2024-12-31 | $185.01M |
| 2024-09-30 | $212.70M |
| 2024-06-30 | $206.24M |
| 2024-03-31 | $212.51M |
| 2023-12-31 | $223.31M |
| 2023-09-30 | $225.54M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.